Cita APA

Roboz, G. J., Kantarjian, H. M., Yee, K. W. L., Kropf, P. L., O'Connell, C. L., Griffiths, E. A., . . . Issa, J. J. (2017). Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia. Cancer.

Chicago Style Citation

Roboz, Gail J., et al. "Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia." Cancer 2017.

Cita MLA

Roboz, Gail J., et al. "Dose, Schedule, Safety, and Efficacy of Guadecitabine in Relapsed or Refractory Acute Myeloid Leukemia." Cancer 2017.